TSC22D1
TSC22 domain family protein 1
Also known as: MGC17597, T22D1_HUMAN, TGFB1I4, TSC22
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15714
- Gene
- TSC22D1
- Ensembl
- ENSG00000102804
- Chromosome
- 13
- Canonical length
- 1073 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nuclear bodies
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the TSC22 domain family of leucine zipper transcription factors. The encoded protein is stimulated by transforming growth factor beta, and regulates the transcription of multiple genes including C-type natriuretic peptide. The encoded protein may play a critical role in tumor suppression through the induction of cancer cell apoptosis, and a single nucleotide polymorphism in the promoter of this gene has been associated with diabetic nephropathy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
1073 residues, UniProt reviewed canonical sequence.
>Q15714|TSC22D1
1 MHQPPESTAA AAAAADISAR KMAHPAMFPR RGSGSGSASA LNAAGTGVGS NATSSEDFPP
61 PSLLQPPPPA ASSTSGPQPP PPQSLNLLSQ AQLQAQPLAP GGTQMKKKSG FQITSVTPAQ
121 ISASISSNNS IAEDTESYDD LDESHTEDLS SSEILDVSLS RATDLGEPER SSSEETLNNF
181 QEAETPGAVS PNQPHLPQPH LPHLPQQNVV INGNAHPHHL HHHHQIHHGH HLQHGHHHPS
241 HVAVASASIT GGPPSSPVSR KLSTTGSSDS ITPVAPTSAV SSSGSPASVM TNMRAPSTTG
301 GIGINSVTGT STVNNVNITA VGSFNPNVTS SMLGNVNIST SNIPSAAGVS VGPGVTSGVN
361 VNILSGMGNG TISSSAAVSS VPNAAAGMTG GSVSSQQQQP TVNTSRFRVV KLDSSSEPFK
421 KGRWTCTEFY EKENAVPATE GVLINKVVET VKQNPIEVTS ERESTSGSSV SSSVSTLSHY
481 TESVGSGEMG APTVVVQQQQ QQQQQQQQQP ALQGVTLQQM DFGSTGPQSI PAVSIPQSIS
541 QSQISQVQLQ SQELSYQQKQ GLQPVPLQAT MSAATGIQPS PVNVVGVTSA LGQQPSISSL
601 AQPQLPYSQA APPVQTPLPG APPPQQLQYG QQQPMVSTQM APGHVKSVTQ NPASEYVQQQ
661 PILQTAMSSG QPSSAGVGAG TTVIPVAQPQ GIQLPVQPTA VPAQPAGASV QPVGQAPAAV
721 SAVPTGSQIA NIGQQANIPT AVQQPSTQVP PSVIQQGAPP SSQVVPPAQT GIIHQGVQTS
781 APSLPQQLVI ASQSSLLTVP PQPQGVEPVA QGIVSQQLPA VSSLPSASSI SVTSQVSSTG
841 PSGMPSAPTN LVPPQNIAQT PATQNGNLVQ SVSQPPLIAT NTNLPLAQQI PLSSTQFSAQ
901 SLAQAIGSQI EDARRAAEPS LVGLPQTISG DSGGMSAVSD GSSSSLAASA SLFPLKVLPL
961 TTPLVDGEDE SSSGASVVAI DNKIEQAMDL VKSHLMYAVR EEVEVLKEQI KELIEKNSQL
1021 EQENNLLKTL ASPEQLAQFQ AQLQTGSPPA TTQPQGTTQP PAQPASQGSG PTALocalizationUniProt · AlphaFold · HPA
Whether an antibody against TSC22D1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.7
- Highest tissue expression
- 338 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 338 nTPM
- cerebral cortex: 257 nTPM
- basal ganglia: 232 nTPM
- midbrain: 213 nTPM
- amygdala: 203 nTPM
- hypothalamus: 178 nTPM
Single-cell type
- platelets: 3,506 nCPM
- choroid plexus epithelial cells: 2,316 nCPM
- late spermatids: 1,684 nCPM
- myonuclei: 1,518 nCPM
- syncytiotrophoblasts: 1,390 nCPM
- thymic myoid cells: 1,190 nCPM
Immune cell
- total PBMC: 50 nTPM
- basophil: 45 nTPM
- plasmacytoid DC: 18 nTPM
- NK-cell: 17 nTPM
- neutrophil: 8.6 nTPM
- eosinophil: 5.8 nTPM
Brain region
- choroid plexus: 282 nTPM
- basal ganglia: 265 nTPM
- midbrain: 258 nTPM
- hippocampal formation: 257 nTPM
- cerebral cortex: 256 nTPM
- thalamus: 256 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.33
- gnomAD pLI
- 0.96
- gnomAD missense Z
- -0.88
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of apoptotic process
- negative regulation of hematopoietic stem cell proliferation
- negative regulation of programmed cell death
- positive regulation of apoptotic process
- positive regulation of cell population proliferation
- positive regulation of programmed cell death
- positive regulation of transforming growth factor beta receptor signaling pathway
- regulation of transcription by RNA polymerase II
- transcription by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TSC22D1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TSC22D1 as an antibody target. Whether an autoantibody or antibody against TSC22D1 could matter depends on whether native TSC22D1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TSC22D1 is annotated at the cell surface, where native TSC22D1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TSC22D1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...